The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo.
Open accessAbstract
We have explored the use of primary myoblasts as a somatic tissue for gene therapy of acquired and inherited diseases where systemic delivery of a gene product may have therapeutic effects. Mouse primary myoblasts were infected with replication-defective retroviruses expressing canine factor IX cDNA under the control of a mouse muscle creatine kinase enhancer and human cytomegalovirus promoter. The infected myoblasts were injected into the hindlegs of recipient mice and levels of secreted factor IX protein were monitored in the plasma. We report sustained expression of factor IX protein for over 6 months without any apparent adverse effect on the recipient mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs
Krieg, P. A., & Melton, D. A. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.18.7057 · Cited by 1,533
Cationic liposome-mediated RNA transfection.
Malone, R. W., Felgner, P. L., & Verma, I. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6077 · Cited by 911
Self-citationHuman gene therapy comes of age
Miller, A. D. (1992) · Nature · doi:10.1038/357455a0 · Cited by 908
Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts
Partridge, T. A., Morgan, J. E., Coulton, G. R., Hoffman, E. P., & Kunkel, L. M. (1989) · Nature · doi:10.1038/337176a0 · Cited by 878
Construction and use of a safe and efficient amphotropic packaging cell line
MARKOWITZ, D., GOFF, S., & BANK, A. (1988) · Virology · doi:10.1016/s0042-6822(88)90101-8 · Cited by 670
Progress Toward Human Gene Therapy
Friedmann, T. (1989) · Science · doi:10.1126/science.2660259 · Cited by 480
Palmer, T. D., Rosman, G. J., Osborne, W. R., & Miller, A. D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1330 · Cited by 479
Systemic Delivery of Human Growth Hormone by Injection of Genetically Engineered Myoblasts
Dhawan, J., Pan, L. C., Pavlath, G. K., Travis, M. A., Lanctot, A. M., & Blau, H. M. (1991) · Science · doi:10.1126/science.1962213 · Cited by 317
Systemic Delivery of Recombinant Proteins by Genetically Modified Myoblasts
Barr, E., & Leiden, J. M. (1991) · Science · doi:10.1126/science.1962212 · Cited by 281
Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants.
Scharfmann, R., Axelrod, J. H., & Verma, I. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4626 · Cited by 280
Self-citation
Cited by
The Basic Science of Gene Therapy
Mulligan, R. C. (1993) · Science · doi:10.1126/science.8493530 · Cited by 1,741
Gene therapy - promises, problems and prospects
Verma, I. M., & Somia, N. (1997) · Nature · doi:10.1038/38410 · Cited by 1,681
Self-citationNaldini, L., Blömer, U., Gage, F. H., Trono, D., & Verma, I. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11382 · Cited by 1,499
Self-citationRando, T. A., & Blau, H. M. (1994) · The Journal of cell biology · doi:10.1083/jcb.125.6.1275 · Cited by 936
Xiao, X., Li, J., & Samulski, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.8098-8108.1996 · Cited by 912
Metadata
- Authors
- Dai, Y., Roman, M., Naviaux, R. K., & Verma, I. M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1992-11-15
- Volume
- 89
- Issue
- 22
- Pages
- 10892-10895
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2078625513
- Cited by
- 302
- References
- 22
- FWCI
- 13.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo. https://app.cochat.ai/papers/10.1073/pnas.89.22.10892
- The paper
- Dai, Y., Roman, M., Naviaux, R. K., & Verma, I. M. (1992). Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.89.22.10892
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.